The Trammpolin® meniscus prosthesis is an investigational implant designed for patients who suffer from persistent knee pain at the medial side of the knee, which is caused by partial or sub-total meniscectomy.
ATRO Medical is conducting their second clinical study (AIR2 study) to investigate whether the Trammpolin® meniscus prosthesis is safe and provides pain relief to the medial side of the knee where meniscal tissue had previously been removed. The clinical study is initiated in October 2021 to enroll 10 patients at select medical centers in the Netherlands. The clinical study is approved by the Dutch government (Dutch Health and Youth Care Inspectorate) and Medical Research Ethics Committee.
CAUTION: Trammpolin® has not yet been approved by regulatory authorities for commercial sale and may only be used in a clinical study. Moreover, by contacting the hospital for an appointment you show your interest in participation in the AIR2 study, but this says nothing about the real possibility to participate. Other factors may exclude you from participation; only the orthopaedic surgeon who performs the examination will determine your final suitability.
The AIR2 study is registered in a clinical study database at Dutch TrialRegister under number NL9805.